Catalyst Pharmaceutical
CPRX
CPRX
313 hedge funds and large institutions have $1.89B invested in Catalyst Pharmaceutical in 2024 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 97 increasing their positions, 105 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1.84% less ownership
Funds ownership: 82.13% → 80.29% (-1.8%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
61% less call options, than puts
Call options by funds: $610K | Put options by funds: $1.58M
Holders
313
Holding in Top 10
3
Calls
$610K
Puts
$1.58M
Top Buyers
| 1 | +$16.1M | |
| 2 | +$10.7M | |
| 3 | +$8.55M | |
| 4 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
+$8.35M |
| 5 |
Goldman Sachs
New York
|
+$7.64M |
Top Sellers
| 1 | -$57.6M | |
| 2 | -$36.1M | |
| 3 | -$11.1M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$10.5M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$9.58M |